tiprankstipranks
Bionovate Technologies (BIIO)
OTHER OTC:BIIO
US Market
BIIO
Bionovate Technologies
RESEARCH TOOLSreports

Bionovate Technologies (BIIO) Income Statement

47 Followers

Bionovate Technologies Income Statement

Last quarter (Q1 2021), Bionovate Technologies's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Bionovate Technologies's net income was $-21.64K. See Bionovate Technologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 21Jun 20Jun 19Jun 18
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 45.37K$ 33.05K$ 56.54K$ 118.88K
Depreciation and Amortization
$ 240.00$ -100.00$ 56.54K$ 118.88K
EBITDA
$ -45.37K$ -33.05K$ -290.00$ 0.00
Operating Income
$ -45.37K$ -33.05K$ -56.54K$ -118.88K
Other Income/Expenses
$ -61.17K$ -88.99K$ -152.35K$ -1.62M
Pretax Income
$ -106.54K$ -122.05K$ -208.90K$ -1.74M
Net Income
$ -106.54K$ -122.05K$ -208.90K$ -1.74M
Per Share Metrics
Basic EPS
$ >-0.01$ >-0.01$ -1.34$ -27.63
Diluted EPS
$ >-0.01$ >-0.01$ -1.34$ -27.46
Weighted Average Shares Outstanding
 7.75M 25.00M 155.00K 63.00K
Weighted Average Shares Outstanding (Diluted)
 7.75M 25.00M 155.80K 63.40K
Currency in USD

Bionovate Technologies Earnings and Revenue History